Annovis Bio’s CEO to Present at H.C. Wainwright Global Investment Conference

Annovis Bio

MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has announced that its Founder, President, and CEO, Maria L. Maccecchini, Ph.D., will be actively participating in the H.C. Wainwright 26th Annual Global Investment Conference. The event will take place from September 9-11, 2024, both virtually and at the Lotte New York Palace Hotel in New York City.

Dr. Maccecchini is set to present on Tuesday, September 10, from 8:00 to 8:30 a.m. ET. She will provide insights into Annovis Bio’s recent advancements and future strategies, followed by a Q&A session. Later that day, from 2:00 to 3:00 p.m. ET, she will engage in a panel discussion titled “Non-amyloid Approaches in Alzheimer’s Disease.” This discussion will feature innovative approaches to Alzheimer’s treatment, with contributions from Anavex Life Sciences Corp. and Longeveron Inc.

This conference is a significant platform for Annovis Bio to showcase its pioneering work in non-amyloid therapies, reflecting its commitment to advancing Alzheimer’s disease treatment.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.

READ:  Vishay Intertechnology Launches Advanced Solid-State Relay